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ess: frode.slinde@nutriSummary Pulmonary rehabilitation is recommended in international treatment
guidelines for chronic obstructive pulmonary disease (COPD). No one has however
studied the effect on long-term mortality. The aim of the current study was to study
the mortality in a sample of patients with severe COPD included in a 1-year
multidisciplinary rehabilitation program. Body composition was assessed at baseline
using bioelectrical impedance. Mortality was studied in 86 patients using the Cox
proportional hazards model. Forty-seven (55%) of the patients died during the mean
follow-up time which was almost 6 years. Risk of mortality increased with increasing
age, increasing number of hospital days the year before inclusion and men had
higher mortality risk than women. The mortality risk decreased with increasing %
reference body weight, increasing fat-free mass index (FFMI), increasing FEV1 and
increasing 6-min walking distance. Gender, age and FFMI continued to be statistical
significant predictors of mortality when controlling for the other baseline variables
in a multivariate analysis. To conclude, body composition, measured by bioelectrical
impedance and presented as FFMI, is an independent predictor of mortality in COPD
patients.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserv
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tion.gu.se (F. Slinde).Introduction
Chronic obstructive pulmonary disease (COPD) is
the fifth leading cause of death in North America
and its prevalence continues to increase, especiallyed.
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studies have investigated factors affecting the
mortality risk in COPD patients.3–7 Common for
most of these studies is that a low body weight or a
low body mass index (BMI) is found to be a major
mortality risk factor. Marquis et al.7 however, in
their study on 142 COPD patients, found that body
composition, measured as midthigh muscle cross-
sectional area obtained by computed tomography
(CT) scan, was a better predictor of mortality than
BMI. However this finding was not confirmed using
body composition assessed by anthropometry.
Studies using simpler and less expensive methods
than CT to assess predictive effect from body
composition were therefore asked for.8
Thomasset9 was the first to report a relation
between total body water and electrical impe-
dance. The use of bioelectrical impedance is based
on the principle that fat mass and fat-free mass (FFM)
have different conductive and dielectric properties.
This is due to the fact that FFM contains water and
therefore has a lower resistance than fat mass.10 An
electrical current is sent through the human body and
the bioelectrical impedance is measured. Relating
the impedance to the conductor’s (the human body)
height gives an assessment of total body water and
hence fat mass and FFM can be calculated.11 The aim
of the current study was to investigate the mortality
in a sample of patients with severe COPD included in
a 1-year multidisciplinary rehabilitation program in
relation to body composition as evaluated by
bioelectrical impedance.Methods
Patients
The patients in this study were included from two
prospective studies of multidisciplinary rehabilita-
tion of COPD patients at the Department of
Respiratory Medicine, Sahlgrenska University Hos-
pital, Go¨teborg, Sweden. The rehabilitation pro-
gram has been presented previously.12 The first
study comprised 50 patients randomized to a
rehabilitation group and a control group. Subjects
in the control group were given ordinary medical
treatment, but no rehabilitation during the control
period. All control subjects, however, went through
an identical 1-year rehabilitation as the cases the
year following the control period. The control
subjects were added as cases in the current
presentation with defining study start as the day
they started the rehabilitation. The second study
comprising 36 patients (to be published), compared
the effect of the rehabilitation program supple-mented by group psychotherapy. In both studies
identical inclusion criteria were applied. Patients
aged 40–75 with COPD with a forced expiratory
volume in 1 s (FEV1)o50% of predicted and with no
demand of oxygen therapy were included. All of the
patients were smokers or former smokers with a
smoking history of at least 10 pack years. Exclusion
criteria were other disabling or severe diseases
and/or coexistence of other causes of impaired
pulmonary function. Patients with a history that
indicated asthma were excluded. None of the
subjects had an acute exacerbation at the time of
inclusion and they were included consecutively.
The decision to make the present analysis was
however retrospective.
Between March 1992 and June 1998, 86 patients
were included in the studies. Patients that survived
were followed from date of inclusion to 1 January
2003, and the ones who died from date of inclusion
to their date of death. The subjects gave written
informed consent to the study and the study was
approved by the Ethics Research Committee of
Go¨teborg University.Study design
Assessment of diet, with the diet history method13
and measurements of FEV1, were performed at
study start and after 12 months. Anthropometric
measurements, bioelectrical impedance assess-
ments, and 6-min walking distance tests were
performed every third month. The 6-min walking
distance test was performed by the same nurse at
each occasion and all patients had one training test
before the study started. Individualized dietary
advice and follow-up by the dietitian were routi-
nely done at study start and after 3, 6, 9, and 12
months and additional visits were individualized for
each patient when judged needed by the dietitian.
The patients trained on a bicycle under the super-
vision of a physiotherapist. Training also included
breathing techniques and arm training. At study
start patients trained twice a week. A home
training program was introduced, which by time
substituted supervised training. The time for
changing from supervised to home based training
was individualized after each patients needs.
Further details of the training program is published
by Engstro¨m et al.12Body composition assessment
Height was measured to the nearest 0.5 cm and
weight was measured on a Lindelltronic Scale to
the nearest 0.1 kg with the subjects in light
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weight of the patients was expressed as a percen-
tage of the weight of a normal Swedish elderly
population,14 defined as % reference weight (%
IBW). Single-frequency bioelectrical impedance
assessment was performed in the morning after
10min rest in the supine position. Impedance was
measured by one single measurement of resistance
(in Ohms) and reactance (in Ohms) with a BIA-101
equipment (Akern Florence, Italy). Short- and long-
term reliability of resistance measurements indi-
cate coefficient of variation between 2.7% and
4.0%.15 The four electrodes were attached on the
dorsal side of the foot and the ankle and on the
dorsal side of the hand and the wrist at the right
side of the body. FFM was calculated using
manufacturer supplied equations, based on com-
parison with densitometry in a normal population.
The fat-free mass index (FFMI) was calculated as
FFM in kg divided by body height2.
Physiological measurements
Routine spirometry was performed with a Vitalo-
graph spirometer (Selefa, Buckingham, Ireland)
before and 15min after inhalation of 1mg terbuta-
line to reach optimal standardization. The 6-min
walking distance tests were performed following
standardized instructions.16
Nutritional assessment and dietary
intervention
A trained dietitian interviewed each patient with a
diet history interview that constituted the back-Table 1 Patient characteristics at baseline and their pr
(SD)), n ¼ 86:
All patients Survivors
(n ¼ 39)
No
sur
(n
Age (years) 65.9 (6.6) 63.6 (7.0) 67
Sex (%F/%M) 49/51 59/41 40
Smokers (% of group) 29 36 23
Hospital days the year
before inclusion
9 (24) 5 (18) 12
BMI (kg/m2) 22.8 (4.1) 23.5 (3.5) 22
Reference body weight (%) 91.4 (16.3) 94.6 (14.1) 88
Fat free mass (kg) 48.6 (9.6) 50.1 (10.7) 47
FFMI (kg/m2) 16.8 (2.3) 17.3 (2.4) 16
Body fat (%) 25.8 (7.2) 25.9 (6.3) 25
FEV1 (% pred) 35 (11) 39 (11) 31
6min walking distance (m) 329 (82) 354 (71) 30
Survivors compared with non-survivors.ground for the individual dietary advice given to
the patients during the rehabilitation. One of the
aims of the dietary advice was to give the patient
an adequate intake of energy, in order to give
maximal effect of physical training and reducing
malnutrition. The normal weight patients were
given dietary advice in order to stabilize the body
weight. Overweight and obese patients were given
individualized weight reducing advice (reduce
energy intake, reduce fat intake, increase intake
of fiber). The underweight patients were given
advice intended to increase their body weight.
They were also offered free availability of nutri-
tional supplements containing energy and micro-
nutrients. Effort was also made to correct
imbalances between the energy-providing nutri-
ents: fat, carbohydrates and protein.
Hospital days
The number of hospital days at Sahlgrenska
University Hospital during the year before study
start was recorded. So was the number of hospital
days from study start to time of death or study end
(1 January 2003).
Statistical analysis
Descriptive statistics were used to describe the
study population at inclusion. Baseline information
was used as independent predictors of mortality in
a univariate analysis based on the Cox proportional
hazards model where survival status at the 1
January 2003 was used as the dependent variable.
Baseline variables that were associated withediction of mortality in an univariate analysis (mean
n-
vivors
¼ 47)
P-
value
Hazard
ratio
95% CI P-value
.7 (5.6) 0.0036 1.06 1.01–1.12 0.013
/60 0.13 1.64 0.92–2.94 0.096
0.24 0.85 0.43–1.68 0.65
(27) 0.18 1.01 1.00–1.02 0.063
.3 (4.4) 0.17 0.95 0.88–1.02 0.17
.8 (17.7) 0.10 0.98 0.97–1.00 0.10
.3 (8.5) 0.18 0.98 0.95–1.01 0.20
.3 (2.2) 0.046 0.88 0.77–1.01 0.061
.6 (8.0) 0.85 1.00 0.96–1.04 0.87
(10) 0.0013 0.96 0.93–0.99 0.0060
7 (85) 0.0087 0.99 0.99–1.00 0.0031
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Body composition and mortality in COPD 1007mortality with a Po0:15 were further on included
in a multivariate analysis based on the Cox
proportional hazards model. To examine differ-
ences between survivors and non-survivors, an
unpaired t-test was used for continuous variables,
and Fisher’s exact test for comparison of propor-
tions. Data were analyzed using the SPSS 11.5 for
Windows statistical package (SPSS Inc., Chicago, IL,
USA).Female            
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Figure 1 Cumulative survival in a group of COPD patients
categorized by FFMI (panel A), gender (panel B), and FEV1
(panel C) (n ¼ 86).Results
Characteristics of the patients (42 women and 44
men) are presented in Table 1. During the rehabi-
litation year three of the patients died, one patient
received oxygen treatment, two patients under-
went major surgery and one patient was diagnosed
for cancer and they are included in the further
analysis. Table 1 show that the survivors were
younger, had a higher FFMI and FEV1 and performed
better on the 6min walking distance. In total there
were 47 deaths (55%) and the causes of death are
presented in Table 2. The causes of death included
in
’ ’
other’’ were stroke, mediastinitis, pulmonary
embolism and drug overdose. Mean follow-up time
for the survivors was 7 years and 3 months. For the
patients who died, it was 4 years and 3 months. The
Cox proportional hazards model presented in Table
1 and Fig. 1, shows that the mortality risk increased
with increasing age, increasing number of hospital
days during the year before inclusion and that men
had higher mortality risk than women. The mortal-
ity risk decreased with increasing percentage
reference body weight, increasing FFMI, increasing
FEV1 and increasing 6-min walking distance. In
addition to gender and age, FFMI continued to be a
statistically significant predictor of mortality when
controlling for the other baseline variables in the
multivariate analysis (Table 3). Changes in some
variables from baseline to end of the rehabilitation
year are presented in Table 4. The results for the
total patient group is presented earlier13 showing
slight, but uniform, indications of positive effects
of the rehabilitation. A larger proportion of theTable 2 Main cause of death, n ¼ 47:
Respiratory failure 19
Chronic obstructive pulmonary disease 9
Heart failure 8
Lung cancer 5
Cancer, other than lung 2
Other 4non-survivors were prescribed nutritional supple-
ments while the survivors had more visits at the
physiotherapist.Discussion
We have shown that body composition, measured
by a non-invasive and relatively simple method, is
an independent predictor of mortality in COPD
patients. The present study supports the findings of
Marquis et al.7 that suggested that body composi-
tion would be a significant predictor of mortality in
COPD patients. In this study we used bioelectrical
impedance assessment, which is a non-invasive,
simple and relatively non-expensive method of
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results were presented as FFMI as recommended by
VanItallie et al.17 It is important that techniques for
body composition analysis are standardized. We
have previously shown that measurements of
bioelectrical impedance used for body composition
assessment need to be highly standardized.18,19 In
the current study, the subjects were measured in
the morning after 10min rest in the supine
position.
However, we could not confirm previous findings
that BMI or body weight are predictors of mortal-
ity.3,4,7 This is in consistency with the findings of
Marquis et al.,7 who found a body composition
measure to be a better predictor of mortality than
BMI. The lack of this relation in the present study
could be due to a limited group size. Except body
composition, old age and male gender also were
found to be independent predictors of mortality inTable 3 Baseline predictors of mortality: multi-
variate analyses, n ¼ 86:
Hazard
ratio
95% CI P-value
Age (years) 1.06 1.00–1.12 0.037
Sex (F/M) 3.52 1.27–9.78 0.016
Hospital days the
year before
inclusion
1.01 0.99–1.02 0.30
Reference body
weight (%)
1.05 0.99–1.10 0.11
FFMI (kg/m2) 0.65 0.44–0.96 0.030
FEV1 (% pred) 0.98 0.95–1.02 0.28
6min walking
distance (m)
1.00 0.99–1.00 0.54
Table 4 Patient characteristics during the rehabilitation
All patients Su
(n
DBMI (kg/m2) 0.0 (1.2) +
DFFM (kg) 0.1 (2.3) 0.
DFFMI (kg/m2) 0.0 (0.8) 0.
DFEV1 (% pred) + 3 (8) +
D6min walking distance (m) + 17 (58) +
Cortisone treatments, n 1.9 (2.2) 1
Visits at the dietitian, n 8.5 (5.0) 7
% of group prescribed
nutritional supplements (%)
51 36
Visits at the physiotherapist, n 25.8 (14.2) 29
Survivors compared with non-survivors.this study. Age is a natural risk factor for death. The
effect of gender is complicated. In the current
study, men did not differ from women in disease
severity (FEV1). Even if the men were older than
the women (Po0:05), the effect of gender on
mortality is shown independently of age. There are
indications from epidemiological studies, that
women are more susceptible than men to develop
COPD,20 but the risk of developing COPD might not
be identical with the severity of the disease when it
has been established. The results of the present
study, however, is in line with other studies
investigating the prognosis in groups of patients
with established COPD, in which poor prognosis in
male patients was shown.1,21–23
The mortality rate in this study is well in line with
results from comparable studies of similar patient
groups performed the last decade. In this study,
55% of the patients died during the mean follow-up
time of 5.6 years, which gives an annual death rate
of 9%. In the study of Marquis et al.7 18% of the
patients died during the 3.4 years of follow-up,
resulting in an annual death rate of 5%. The
patients in that study had however somewhat less
severe disease (mean FEV1 was 42% predicted
compared with 35% predicted in the current study).
In a Canadian study24 47% of the patients died
during the follow-up of almost 3 year, giving an
annual death rate of 16%. In that study, mean FEV1
was 27% predicted, and they also included patients
receiving oxygen treatment, indicating a lower
pulmonary function and hence a higher mortality
rate would be expected. Thus approximately 50% of
patients with severe COPD included in rehabilita-
tion programs can be expected to die within 5
years. Thus the prognosis in advanced COPD is
worse than for most forms of malignant
diseases.25year (mean (SD)), n ¼ 86:
rvivors
¼ 39)
Non-survivors
(n ¼ 47)
P-value
0.1 (1.1) 0.2 (1.2) 0.25
0 (2.4) 0.2 (2.4) 0.69
0 (0.8) 0.1 (0.8) 0.61
3 (8) + 3 (8) 0.77
27 (56) + 6 (59) 0.12
.4 (1.5) 2.4 (2.6) 0.069
.6 (4.7) 9.3 (5.1) 0.10
64 0.017
.2 (13.0) 23.0 (14.7) 0.042
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tion, measured by bioelectrical impedance and
presented as FFMI, is an independent predictor of
mortality in COPD patients.Acknowledgments
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